Attached files
file | filename |
---|---|
EX-32.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC. | d264862dex322.htm |
EX-21.1 - SUBSIDIARIES - AVEO PHARMACEUTICALS, INC. | d264862dex211.htm |
EX-32.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC. | d264862dex321.htm |
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC. | d264862dex312.htm |
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC. | d264862dex311.htm |
EX-10.8 - FORM OF RESTRICTED STOCK AGREEMENT - AVEO PHARMACEUTICALS, INC. | d264862dex108.htm |
EX-10.25 - AMENDMENT NO. 1 TO LOAN & SECURITY AGREEMENT - AVEO PHARMACEUTICALS, INC. | d264862dex1025.htm |
EX-10.29 - FIRST AMENDMENT TO SUBLEASE - AVEO PHARMACEUTICALS, INC. | d264862dex1029.htm |
EX-10.23 - EXTENSION LETTER AMENDMENT - AVEO PHARMACEUTICALS, INC. | d264862dex1023.htm |
EXCEL - IDEA: XBRL DOCUMENT - AVEO PHARMACEUTICALS, INC. | Financial_Report.xls |
10-K - FORM 10-K - AVEO PHARMACEUTICALS, INC. | d264862d10k.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-165530 and 333-175390 and Form S-3 Nos. 333-178756 and 333-174254) of AVEO Pharmaceuticals, Inc. and in the related Prospectus of our reports dated March 30, 2012, with respect to the consolidated financial statements of AVEO Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of AVEO Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ ERNST & YOUNG LLP
Boston, Massachusetts
March 30, 2012